MedTrace Logo

Evaluation of the Tolerance and Safety of a New Partly Fermented Anti-regurgitation Infant Formula

NCT03371615 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 182

Last updated 2021-12-30

No results posted yet for this study

Summary

A randomised, controlled, double-blind trial to evaluate the tolerance and safety of a new partly fermented anti-regurgitation infant formula containing prebiotics and locust bean gum in infants with regurgitation.

Conditions

  • Regurgitation, Gastric

Interventions

OTHER

Anti-regurgitation infant formula

Anti regurgitation infant formula

Sponsors & Collaborators

  • Nutricia Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Weeks
Max Age
13 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-04
Primary Completion
2019-09-06
Completion
2019-09-06

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03371615 on ClinicalTrials.gov